These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7737971)

  • 1. Ca(2+)-dependent binding of human serum amyloid P component to Alzheimer's beta-amyloid peptide.
    Hamazaki H
    J Biol Chem; 1995 May; 270(18):10392-4. PubMed ID: 7737971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of human serum amyloid P component and heparan sulfate proteoglycan in in vitro-formed Abeta fibrils.
    Holm Nielsen E; Nybo M; Junker K; Toftedal Hansen P; Rasmussen IM; Svehag SE
    Scand J Immunol; 2000 Aug; 52(2):110-2. PubMed ID: 10931376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo.
    Al-Shawi R; Tennent GA; Millar DJ; Richard-Londt A; Brandner S; Werring DJ; Simons JP; Pepys MB
    Open Biol; 2016 Feb; 6(2):150202. PubMed ID: 26842068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congo red inhibits proteoglycan and serum amyloid P binding to amyloid beta fibrils.
    Gupta-Bansal R; Brunden KR
    J Neurochem; 1998 Jan; 70(1):292-8. PubMed ID: 9422374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro.
    Ozawa D; Nomura R; Mangione PP; Hasegawa K; Okoshi T; Porcari R; Bellotti V; Naiki H
    Sci Rep; 2016 Jul; 6():29077. PubMed ID: 27380955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential association of serum amyloid P component with fibrillar deposits in familial British and Danish dementias: similarities with Alzheimer's disease.
    Rostagno A; Lashley T; Ng D; Meyerson J; Braendgaard H; Plant G; Bojsen-Møller M; Holton J; Frangione B; Revesz T; Ghiso J
    J Neurol Sci; 2007 Jun; 257(1-2):88-96. PubMed ID: 17374542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Alzheimer beta-peptide fibril formation by serum amyloid P component.
    Janciauskiene S; García de Frutos P; Carlemalm E; Dahlbäck B; Eriksson S
    J Biol Chem; 1995 Nov; 270(44):26041-4. PubMed ID: 7592799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.
    Castillo GM; Ngo C; Cummings J; Wight TN; Snow AD
    J Neurochem; 1997 Dec; 69(6):2452-65. PubMed ID: 9375678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum amyloid P component binding to C4b-binding protein.
    García de Frutos P; Härdig Y; Dahlbäck B
    J Biol Chem; 1995 Nov; 270(45):26950-5. PubMed ID: 7592941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca2+-mediated association of human serum amyloid P component with heparan sulfate and dermatan sulfate.
    Hamazaki H
    J Biol Chem; 1987 Feb; 262(4):1456-60. PubMed ID: 2948956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-ligand interactions between serum amyloid P component and model soluble immune complexes.
    Brown MR; Anderson BE
    J Immunol; 1993 Aug; 151(4):2087-95. PubMed ID: 8393897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-mediated binding of the acute-phase reactant mouse serum amyloid P-component (SAP) to macrophages.
    Siripont J; Tebo JM; Mortensen RF
    Cell Immunol; 1988 Dec; 117(2):239-52. PubMed ID: 3143483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human serum amyloid P-component (SAP) selectively binds to immobilized or bound forms of C-reactive protein (CRP).
    Swanson SJ; Christner RB; Mortensen RF
    Biochim Biophys Acta; 1992 Dec; 1160(3):309-16. PubMed ID: 1477104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of the binding interaction between human serum amyloid P-component and immobilized human C-reactive protein.
    Christner RB; Mortensen RF
    J Biol Chem; 1994 Apr; 269(13):9760-6. PubMed ID: 8144569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs.
    Pepys MB
    Front Immunol; 2018; 9():2382. PubMed ID: 30459761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-dependent and -independent binding of the pentraxin serum amyloid P component to glycosaminoglycans and amyloid proteins: enhanced binding at slightly acid pH.
    Danielsen B; Sørensen IJ; Nybo M; Nielsen EH; Kaplan B; Svehag SE
    Biochim Biophys Acta; 1997 Apr; 1339(1):73-8. PubMed ID: 9165101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
    Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
    Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of divalent metal ions and pH upon the binding reactivity of human serum amyloid P component, a C-reactive protein homologue, for zymosan. Preferential reactivity in the presence of copper and acidic pH.
    Potempa LA; Kubak BM; Gewurz H
    J Biol Chem; 1985 Oct; 260(22):12142-7. PubMed ID: 4044589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum amyloid P component accelerates the formation and enhances the stability of amyloid fibrils in a physiologically significant under-saturated solution of amyloid-β42.
    Mold M; Shrive AK; Exley C
    J Alzheimers Dis; 2012; 29(4):875-81. PubMed ID: 22337829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.
    Pepys MB; Herbert J; Hutchinson WL; Tennent GA; Lachmann HJ; Gallimore JR; Lovat LB; Bartfai T; Alanine A; Hertel C; Hoffmann T; Jakob-Roetne R; Norcross RD; Kemp JA; Yamamura K; Suzuki M; Taylor GW; Murray S; Thompson D; Purvis A; Kolstoe S; Wood SP; Hawkins PN
    Nature; 2002 May; 417(6886):254-9. PubMed ID: 12015594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.